World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 13 January 2015
Main ID:  ISRCTN25455020
Date of registration: 21/11/2005
Prospective Registration: Yes
Primary sponsor: University Hospital Tuebingen (Germany)
Public title: Cognitive behavioural treatment of negative symptoms in patients with schizophrenic disorders
Scientific title:
Date of first enrolment: 01/01/2006
Target sample size: 198
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN25455020
Study type:  Interventional
Study design:  Randomised controlled trial (Treatment)  
Phase: 
Countries of recruitment
Germany
Contacts
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Name: Stefan    Klingberg
Address:  Department of Psychiatry and Psychotherapy Osianderstr. 24 D-72076 Tuebingen Germany
Telephone:
Email: stefan.klingberg@med.uni-tuebingen.de
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. Schizophrenia (Diagnostic and Statistical Manual of Mental Disorders - fourth edition [DSM-IV] 295.1, 295.2, 295.3, 295.4, 295.6, 295.9)
2. PANSS Modified Negative Syndrome Score =10
3. Fluency of German language

Exclusion criteria: 1. Severe positive symptoms (any item of the standard PANSS positive scale [P1, P2, P3, P4, P5, P6, P7] =6)
2. Severe depression as indicated by PANSS G6 =6
3. Extrapyramidal symptoms
4. Age below 18 or over 55
5. Organic disorder interfering with the central nervous system
6. Verbal IQ <80
7. Diagnosis of substance abuse or substance dependence according to DSM-IV/Structured Clinical Interview for Depression (SCID-I) as primary clinical problem
8. Travel time to the study centre of more than 1 hour


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Schizophrenia
Mental and Behavioural Disorders
Schizophrenia
Intervention(s)
Cognitive Behavioural Treatment versus Cognitive Remediation
Primary Outcome(s)
PANSS Modified Negative Factor (N1, N2, N3, N4, N6, G7, G16)
Secondary Outcome(s)
1. Illness related events
2. Scale for the Assessment of Negative Symptoms (SANS)
3. Calgary Depression Scale for Schizophrenia (CDSS)
4. Clinical Global Impression (CGI)
5. Lancashire Quality of Life Profile (LQLP)
6. Social Status
7. Medication Compliance
8. Symptom Checklist 90 Revised (SCL-90-R)
9. Frontal Eye Fields (FEF)
10. Frankfurt Self-concept Scale (FSKN)
11. Neuropsychological assessment
Secondary ID(s)
KL1179/3-1
Source(s) of Monetary Support
German Research Foundation (Deutsche Forschungsgemeinschaft) (Germany), grant KL1179/3-1
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history